|1.||Buck, R: 1 article (09/2015)|
|2.||Han, S: 1 article (09/2015)|
|3.||Lee, S: 1 article (09/2015)|
|4.||Forsythe, P: 1 article (09/2015)|
|5.||Castillo-Courtade, L: 1 article (09/2015)|
|6.||Mian, F M: 1 article (09/2015)|
|7.||Nonaka, Ikuya: 1 article (10/2014)|
|8.||Cho, Anna: 1 article (10/2014)|
|9.||Noguchi, Satoru: 1 article (10/2014)|
|10.||Hayashi, Yukiko K: 1 article (10/2014)|
|1.||Muscular Diseases (Myopathy)
10/01/2014 - "6'-sialyllactose ameliorated muscle atrophy and degeneration in symptomatic GNE myopathy mice. "
10/01/2014 - "Our results provide evidence that GNE myopathy can be treated even at a progressive stage and 6'-sialyllactose has more remarkable advantage than free sialic acid, providing a conceptual proof for clinical use in patients."
|2.||Muscular Atrophy (Muscle Atrophy)
|4.||Food Hypersensitivity (Food Allergy)
09/01/2015 - "Our results suggest that 2'-fucosyllactose and 6'-sialyllactose reduce the symptoms of food allergy through induction of IL-10(+) T regulatory cells and indirect stabilization of mast cells. "
09/01/2015 - "Here, we assess the effect of two HMOs, 2'-fucosyllactose and 6'-sialyllactose, on symptomatology and immune responses in an ovalbumin-sensitized mouse model of food allergy. "
09/01/2015 - "Daily oral treatment with 2'-fucosyllactose or 6'-sialyllactose attenuated food allergy symptoms including diarrhea and hypothermia. "
|1.||N-Acetylneuraminic Acid (Sialic Acid)